… baumannii clinical isolates from Brazil that represent the major … tant to minocycline, and
4.1% resistant to colistin. Sulbactam … with imipenem-resistant Acinetobacter baumannii treated …

… moderately imipenem-resistant isolates. A study analyzing MDR … combination is represented
by colistin plus rifampin. A recent study has demonstrated that the in vitro activity of colistin …

… with resistance to gentamicin, minocycline, and ceftazidime (P<… in a clinical trial against
imipenem-resistant strains. Citation193 … alone and in combination against clinical isolates of A. …

… baumannii included resistance to sulbactam, minocycline or … imipenem-resistant isolates,
all 14 isolates of Acinetobacter … Recent clinical isolates of Acinetobacter spp. in Korea were …

… combinations in vitro were colistin + … the combinations were likely to be the most useful
clinically, we applied the SBPI to rank the results. In the example, colistin + aztreonam and colistin …

… However, clinical isolates of A. … The rate of imipenem-resistant Acinetobacter in a Spanish
hospital changed … In the same study, 50% and 20% were not susceptible to minocycline and …

… involving multiresistant Acinetobacter clinical isolates. … 10 (90%) patients with
imipenem-resistant A. calcoaceticus infections … shown to be active against Acinetobacter is colistin …

… Yet, the risk for end-of-treatment mortality may be reduced with longer duration of colistin …
baumannii. It is the first of a novel class of minocycline derivatives known as the glycylcyclines. …

… combination with an antibiotic called colistin, can help treat … Spread of imipenem-resistant
Acinetobacter baumannii co-… with minocycline in treating Acinetobacter baumannii infection…

… Outer membrane protein CarO gene was not detected in four imipenem-resistant isolates. …
In vitro and animal studies support the role of combination therapy of colistin with fosfomycine …